… The results of large clinical trials with dietary supplementation of folic acid, vitamin B12 and
… Folic acid supplementation appears as a reasonable therapeutic option in patients affected …

… increased consumption of folic acid vitamin supplements and … consumption of folic acid by
0.1 to 0.25 mg of folic acid a day is … policy option is available: require that all folic acid vitamin …

… and folinic acid demonstrated a significant survival advantage compared to fluorouracil and
folinic acid … In this article, we will review the literature regarding existing treatment options for …

… the usefulness of folic acid supplementation. … of folic acid supplementation in patients
treated with methotrexate for inflammatory diseases. We also investigated whether folic acid …

… This is a retrospective single-center analysis of all patients who have been treated with
nal-IRI plus 5-FU/LV. To compare its effectiveness with other second-line treatment options, all …

… This is a better option than reducing the dose of methotrexate93. Important to this … arthritis
were treated with low dose methotrexate (< 20 mg/week) concurrently with folic or folinic acid, …

… folic or folinic acid in MTX treated rheumatoid arthritis patients provides a reduction in the
incidence of abnormal liver function tests and a reduction in overall withdrawal from treatment. …

… , fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) and gemcitabine combined with
nab-paclitaxel have emerged as new first-line treatment options. Both regimens significantly …

… treatment option most of the time. LV rescue starts 24 h after the start of MTX infusion at a
dose of 15 mg/m 2 IV push every 6 h for 3 days and should be continued until serum MTX …

… Overall the sequential treatment with FOLFIRI and FOLFOX (or the opposite) should be
considered as the preferred treatment option, especially for the addition of molecular targeted …